The table below shows Avidity Biosciences, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Q1 2024
Revenue
$12.47M
$3.85M
$1.57M
$2.34M
$2.04M
$3.54M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$154.95M
$138.13M
$99.49M
$77.20M
$63.94M
$66.83M
SG&A
RNA annual revenue (10-K history)
Avidity Biosciences, Inc. reported annual revenue of $18.75M for fiscal year 2025. That is up 72.1% from $10.90M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $379.00K (FY 2018) to $18.75M. Figures come from the company's audited annual reports as filed with the SEC.
